IP Library Granted Patent US 10,023,537
Granted Patent B2
US 10,023,537 · App. 15/147,021 · Granted Jul 17, 2018

Heterocyclic compounds for the treatment of neurological and psychological disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,023,537
App. No.
15/147,021
Granted
Jul 17, 2018
Kind
B2
Abstract

Lactam compounds of Formula I and their use for the treatment of neurological and psychiatric disorders including schizophrenia, bipolar disorder, anxiety disorder and insomnia is disclosed.

Claims (23)

1. A method for the synthesis of a compound of Formula XXIV:

comprising the step of reacting a compound of Formula XXIII:

with an aldehyde or ketone of formula (R 101 )C(O)(R 103 ),

wherein represents a single or double bond;

semicircle represents an optionally substituted aryl, containing one, two or three rings;

A is selected from absent, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, —S—, —O—, —S(O)—, —S(O) 2 —, —S[C(R 10 )(R 11 )] u —, —S(O) [C(R 10 )(R 11 )] u —, —S(O) 2 [C(R 10 )(R 11 )] u —,—O[C(R 10 )(R 11 )] u —, —N(R 10 )—, —N(R 10 )—[C(R 10 )(R 11 )] u —, —[C(R 10 )(R 11 )] u ;

wherein each u is independently 1, 2, 3, 4, 5, 6 or 7;

wherein each R 10 and R 11 is independently absent, hydrogen, halogen, aliphatic, substituted aliphatic, aryl or substituted aryl;

Cy 1 is an optionally substituted cycloalkyl, optionally substituted cycloalkenyl, optionally substituted heterocyclyl or optionally substituted aryl;

B is a direct bond, a straight chain C 1 -C 10 alkyl, C 1 -C 10 alkenyl, C 1-C 10 alkynyl, C 1 -C 10 alkoxy, alkoxyC 1 -C 10 alkoxy, C 1 -C 10 alkylamino, alkoxyC 1 -C 10 alkylamino, C 1 -C 10 alkylcarbonylamino, C 1 -C 10 alkylaminocarbonyl, aryloxyC 1 -C 10 alkoxy, aryloxyC 1 -C 10 alkylamino, aryloxyC 1 -C 10 alkylamino carbonyl, C 1 -C 10 -alkylaminoalkylaminocarbonyl, C 1 -C 10 alkyl(N-alkyl)aminoalkyl-aminocarbonyl, alkylaminoalkylamino, alkylcarbonylaminoalkylamino, alkyl(N-alkyl)aminoalkylamino, (N-alkyl)alkylcarbonylaminoalkylamino, alkylaminoalkyl, alkylaminoalkylaminoalkyl, alkylpiperazinoalkyl, piperazinoalkyl, alkylpiperazino, alkenylaryloxyC 1-C 10 alkoxy, alkenylarylaminoC 1 -C 10 alkoxy, alkenylaryllalkylaminoC 1 -C 10 alkoxy, alkenylaryloxyC 1 -C 10 alkylamino, alkenylaryloxyC 1 -C 10 alkylaminocarbonyl, piperazinoalkylaryl, heteroarylC 1 -C 10 alkyl, heteroarylC 2 -C 10 alkenyl, heteroarylC 2 -C 10 alkynyl, heteroarylC 1 -C 10 alkylamino, heteroarylC 1 -C 10 alkoxy, heteroaryloxyC 1 -C 10 alkyl, heteroaryloxyC 2 -C 10 alkenyl, heteroaryloxyC 2 -C 10 alkynyl, heteroaryloxyC 1 -C 10 alkylamino or heteroaryloxyC 1 -C 10 alkoxy;

D is selected from absent, —O—, —NR 10 , —C(R 10 )(R 11 )— and —S—, —S(O)—, —S(O) 2 —, —C(O)—;

G 1 is present or absent, and each G 1 and G 2 is independently selected from —S—, —O—, —S(O)—, —S(O) 2 —, —SC(R 10 )(R 11 )—, —S(O) C(R 10 )(R 11 )—, —S(O) 2 C(R 10 )(R 11 )—, —OC(R 10 )(R 11 )—, —N(R 10 )—, —C(R 10 )═C(R 11 )—, —N(R 10 )—C(R 10 )(R 11 )—, or —[C(R 10 )(R 11 )] t —;

wherein t is 1, 2 or 3;

Each R 1 , R 3 and R 4 is independently selected from absent, hydrogen, halogen, —OR 10 ,—SR 10 , —N(R 10 )(R 11 ), —S(O)R 10 , —S(O) 2 R 10 , optionally substituted aliphatic, optionally substituted aryl or optionally substituted heterocyclyl;

alternatively, two R 3 and R 4 together form an optionally substituted ring; and

wherein R 101 and R 103 are independently selected from hydrogen, halogen, optionally substituted C 1 -C 8 alkyl, optionally substituted C 2 -C 8 alkenyl, optionally substituted C 2 -C 8 alkynyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 1 -C 8 alkoxy, optionally substituted C 1 -C 8 alkylamino and optionally substituted C 1 -C 8 aryl; and

wherein m and q are independently selected from 0, 1, and 2.

2. The method according to claim 1 , wherein said aldehyde is paraformaldehyde.

3. The method according to claim 1 further comprising the step of reacting said compound of formula XXIV with an acid anhydride to form a compound formula XXVI,

wherein R 100 has the same meaning as R 102 and R 103 .

4. The method according to claim 3 , wherein said acid anhydride is selected from acetic anhydride, butyric anhydride, hexanoic anhydride, octanoic anhydride, decanoic anhydride, dodecanoic anhydride, lauric anhydride, and palmitic anhydride.

5. The method according to claim 1 , wherein the compound of Formula XXIII is reacted with an aldehyde.

6. The method according to claim 1 , wherein the compound of Formula XXIV has the formula:

Assignments (8)
RELEASE OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (073213/0302) Recorded Feb 13, 2026
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 074858/0429 →
SECURITY INTEREST Recorded Feb 13, 2026
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 074858/0405 →
SECURITY INTEREST Recorded Oct 23, 2025
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 073213/0302 →
RELEASE OF PATENT SECURITY AGREEMENTS Recorded Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 069771/0701 →
SECURITY INTEREST Recorded Mar 20, 2020
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 052914/0832 →
SECURITY INTEREST Recorded Dec 3, 2018
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 047661/0244 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: ALKERMES, INC.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 044698/0993 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: REMENAR, JULIUS F.; BLUMBERG, LAURA COOK; ZEIDAN, TAREK A.
To: ALKERMES, INC.
Reel/Frame 044698/0678 →